St. Jude Medical is seeking the retraction of an article by Robert Hauser in Heart Rhythm linking the company’s Riata and Riata ST leads to 20 or more deaths. In a press release (see below) issued on Friday afternoon, St. Jude alleges numerous mistakes and oversights in the Hauser paper.
In a brief statement to CardioBrief, Hauser wrote:
We stand by the conclusion of our study, namely: “Riata and Riata ST ICD leads appear prone to high-voltage failures that have resulted in multiple deaths.”
In response to a message thread on CafePharma, St. Jude seeks retraction of Hauser’s manuscript, one anonymous observer started a new thread: Patients seek retraction of their STJ leads.
Dr. Wes has a great perspective on this story.
Click here to review our previous coverage of the Riata controversy.
Click here to read the St. Jude Medical press release…
Old CardioBrief 